Chapter 15 : Active Drug Efflux in Bacteria

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Active Drug Efflux in Bacteria, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815615/9781555813031_Chap15-1.gif /docserver/preview/fulltext/10.1128/9781555815615/9781555813031_Chap15-2.gif


The major facilitator superfamily (MFS) comprises drug-specific pumps like the - and -encoded tetracycline transporters found in many gram-positive bacteria and gram-negative bacteria. The majority of macrolide-resistant pneumococci in the United States, Canada, South America, Hong Kong, Singapore, Thailand, and Malaysia were cases of -mediated resistance. Fluoroquinolone resistance in gram-negative bacteria due to target site alteration can be substantially supported by efflux. Multiple-antibiotic-resistant (mar) mutants of have decreased outer membrane permeability due to reduced porin expression and at the same time show increased efflux. An interesting aspect of the VceC structure is that the resolved positions of two octyl-β-glucoside molecules were as expected for lipopolysaccharides (LPS) of the bacterial outer membrane. The majority of the multidrug and toxic compound extrusion family (MATE) transporters identified until now use the electro-chemical potential of Na across the membrane to drive multidrug export. Multidrug ABC transporters contribute to multiple antibiotic resistance in bacteria and cause multiple-cancer-drug resistance in humans. Apart from contributing to resistance against anticancer chemotherapy, drug efflux is highly relevant for the successful treatment of bacterial infections by tetracycline, macrolide, and fluoroquinolone antibiotics. NorA in , PmrA in , and (clinically less relevant) Bmr and Blt in are clear examples of the high relevance of drug efflux for fluoroquinolone resistance in gram-positive bacteria. The MFS members CmlA and FloR specifically export chloramphenicol and the structurally related veterinary drug florfenicol. They confer inducible resistance in many gram-negative bacteria including , , and the .

Citation: Dreier J. 2007. Active Drug Efflux in Bacteria, p 235-264. In Bonomo R, Tolmasky M (ed), Enzyme-Mediated Resistance to Antibiotics. ASM Press, Washington, DC. doi: 10.1128/9781555815615.ch15

Key Concept Ranking

Antibacterial Agents
Small Multidrug Resistance Family
Bacterial Outer Membrane Proteins
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 15.1
Figure 15.1

Schematic representations of different drug efflux systems. The shapes depict major characteristics where known. More-detailed information about the topology, occurrence in different organisms, and function is given in the text and in Table 15.1 .

Citation: Dreier J. 2007. Active Drug Efflux in Bacteria, p 235-264. In Bonomo R, Tolmasky M (ed), Enzyme-Mediated Resistance to Antibiotics. ASM Press, Washington, DC. doi: 10.1128/9781555815615.ch15
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 15.2
Figure 15.2

Three-dimensional structure of a MexA monomer from (Protein Data Base [PDB] code 1vf7).

Citation: Dreier J. 2007. Active Drug Efflux in Bacteria, p 235-264. In Bonomo R, Tolmasky M (ed), Enzyme-Mediated Resistance to Antibiotics. ASM Press, Washington, DC. doi: 10.1128/9781555815615.ch15
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 15.3
Figure 15.3

Model for a tripartite AcrAB-TolC efflux system. The hypothetical collar-like structure of an AcrA multimer is indicated by the sketch, which overlaps the AcrB and TolC trimers. The boundaries of lipid bilayers are indicated as black lines.

Citation: Dreier J. 2007. Active Drug Efflux in Bacteria, p 235-264. In Bonomo R, Tolmasky M (ed), Enzyme-Mediated Resistance to Antibiotics. ASM Press, Washington, DC. doi: 10.1128/9781555815615.ch15
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Abramson, J.,, S. Iwata, and, H. R. Kaback. 2004. Lactose permease as a paradigm for membrane transport proteins. Mol. Membr. Biol. 21:227236.
2. Abramson, J.,, I. Smirnova,, V. Kasho,, G. Verner,, H. R. Kaback, and, S. Iwata. 2003. Structure and mechanism of the lactose permease of Escherichia coli. Science 301:610615.
3. Adler, J., and, E. Bibi. 2004. Determinants of substrate recognition by the Escherichia coli multidrug transporter MdfA identified on both sides of the membrane. J. Biol. Chem. 279:89578965.
4. Adler, J., and, E. Bibi. 2005. Promiscuity in the geometry of electrostatic interactions between the Escherichia coli multi-drug resistance transporter MdfA and cationic substrates. J. Biol. Chem. 280:27212729.
5. Adler, J.,, O. Lewinson, and, E. Bibi. 2004. Role of a conserved membrane-embedded acidic residue in the multidrug transporter MdfA. Biochemistry 43:518525.
6. Aendekerk, S.,, S. P. Diggle,, Z. Song,, N. Hoiby,, P. Cornelis,, P. Williams, and, M. Camara. 2005. The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology 151:11131125.
7. Aires, J. R., and, H. Nikaido. 2005. Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. Bacteriol. 187:19231929.
8. Akama, H.,, M. Kanemaki,, M. Yoshimura,, T. Tsukihara,, T. Kashiwagi,, H. Yoneyama,, S. Narita,, A. Nakagawa, and, T. Nakae. 2004. Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aerugi-nosa: dual modes of membrane anchoring and occluded cavity end. J. Biol. Chem. 279:5281652819.
9. Akama, H.,, T. Matsuura,, S. Kashiwagi,, H. Yoneyama,, S. Narita,, T. Tsukihara,, A. Nakagawa, and, T. Nakae. 2004. Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem. 279:2593925942.
10. Alam, M. M.,, N. Kobayashi,, N. Uehara, and, N. Watanabe. 2003. Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 9:109121.
11. Alonso, A., and, J. L. Martinez. 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Che-mother. 44:30793086.
12. Alos, J. I.,, B. Aracil,, J. Oteo,, C. Torres, and, J. L. Gomez-Garces. 2000. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. J. Antimicrob. Chemother. 45:605609.
13. Ambrose, K. D.,, R. Nisbet, and, D. S. Stephens. 2005. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible. Antimicrob. Agents Chemother. 49:42034209.
14. Ambudkar, S. V.,, S. Dey,, C. A. Hrycyna,, M. Ramachandra,, I. Pastan, and, M. M. Gottesman. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:361398.
15. Andersen, C.,, C. Hughes, and, V. Koronakis. 2000. Chunnel vision. Export and efflux through bacterial channel-tunnels. EMBO Rep. 1:313318.
16. Andersen, C.,, C. Hughes, and, V. Koronakis. 2002. Electro-physiological behavior of the TolC channel-tunnel in planar lipid bilayers. J. Membr. Biol. 185:8392.
17. Andersen, C.,, E. Koronakis,, E. Bokma,, J. Eswaran,, D. Humphreys,, C. Hughes, and, V. Koronakis. 2002. Transition to the open state of the TolC periplasmic tunnel entrance. Proc. Natl. Acad. Sci. USA 99:1110311108.
18. Andersen, C.,, E. Koronakis,, C. Hughes, and, V. Koronakis. 2002. An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations. Mol. Microbiol. 44:11311139.
19. Asako, H.,, H. Nakajima,, K. Kobayashi,, M. Kobayashi, and, R. Aono. 1997. Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli. Appl. Environ. Microbiol. 63:14281433.
20. Athappilly, F. K., and, W. A. Hendrickson. 1995. Structure of the biotinyl domain of acetyl-coenzyme A carboxylase determined by MAD phasing. Structure 3:14071419.
21. Augustus, A. M.,, T. Celaya,, F. Husain,, M. Humbard, and, R. Misra. 2004. Antibiotic-sensitive TolC mutants and their suppressors. J. Bacteriol. 186:18511860.
22. Avila-Sakar, A. J.,, S. Misaghi,, E. M. Wilson-Kubalek,, K. H. Downing,, H. Zgurskaya,, H. Nikaido, and, E. Nogales. 2001. Lipid-layer crystallization and preliminary three-dimensional structural analysis of AcrA, the periplasmic component of a bacterial multidrug efflux pump. J. Struct. Biol. 136:8188.
23. Barbosa, T. M., and, S. B. Levy. 2000. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J. Bacteriol. 182:34673474.
24. Barrett, J. F. 2001. MC-207110 Daiichi Seiyaku/Microcide Pharmaceuticals. Curr. Opin. Investig. Drugs 2:212215.
25. Baucheron, S.,, S. Tyler,, D. Boyd,, M. R. Mulvey,, E. Chaslus-Dancla, and, A. Cloeckaert. 2004. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob. Agents Che-mother. 48:37293735.
26. Belofsky, G.,, D. Percivill,, K. Lewis,, G. P. Tegos, and, J. Ekart. 2004. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J. Nat. Prod. 67:481484.
27. Benz, R.,, E. Maier, and, I. Gentschev. 1993. TolC of Escherichia coli functions as an outer membrane channel. Zentbl. Bakteriol. 278:187196.
28. Berg, A.,, J. Vervoort, and, A. de Kok. 1997. Three-dimensional structure in solution of the N-terminal lipoyl domain of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Eur. J. Biochem. 244:352360.
29. Bert, F.,, Z. Ould-Hocine,, M. Juvin,, V. Dubois,, V. Loncle-Provot,, V. Lefranc,, C. Quentin,, N. Lambert, and, G. Arlet. 2003. Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa. J. Clin. Microbiol. 41:37123718.
30. Bertrand, X.,, P. Bailly,, G. Blasco,, P. Balvay,, A. Boillot, and, D. Talon. 2000. Large outbreak in a surgical intensive care unit of colonization or infection with Pseudomonas aerugi-nosa that overexpressed an active efflux pump. Clin. Infect. Dis. 31:E9E14.
31. Betriu, C.,, I. Rodriguez-Avial,, B. A. Sanchez,, M. Gomez,, J. Alvarez, and, J. J. Picazo. 2002. In vitro activities of tigecy-cline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob. Agents Chemother. 46:892895.
32. Beyer, R.,, E. Pestova,, J. J. Millichap,, V. Stosor,, G. A. Noskin, and, L. R. Peterson. 2000. A convenient assay for estimating the possible involvement of efflux of fluoroqui-nolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux. Antimicrob. Agents Chemother. 44:798801.
33. Bohnert, J. A., and, W. V. Kern. 2005. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49:849852.
34. Bonomo, R. A., and, D. Szabo. 2006. Mechanisms of multi-drug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43(Suppl. 2):S49S56.
35. Borges-Walmsley, M. I.,, J. Beauchamp,, S. M. Kelly,, K. Jumel,, D. Candlish,, S. E. Harding,, N. C. Price, and, A. R. Walmsley. 2003. Identification of oligomerization and drug-binding domains of the membrane fusion protein EmrA. J. Biol. Chem. 278:1290312912.
36. Borges-Walmsley, M. I.,, K. S. McKeegan, and, A. R. Walms-ley. 2003. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 376:313338.
37. Bou, G.,, G. Cervero,, M. A. Dominguez,, C. Quereda, and, J. Martinez-Beltran. 2000. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter bauman-nii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J. Clin. Microbiol. 38:32993305.
38. Bouige, P.,, D. Laurent,, L. Piloyan, and, E. Dassa. 2002. Phylogenetic and functional classification of ATP-binding cassette (ABC) systems. Curr. Protein Pept. Sci. 3:541559.
39. Bozdogan, B.,, P. C. Appelbaum,, L. M. Kelly,, D. B. Hoell-man,, A. Tambic-Andrasevic,, L. Drukalska,, W. Hryniewicz,, H. Hupkova,, M. R. Jacobs,, J. Kolman,, M. Konkoly-Thege,, J. Miciuleviciene,, M. Pana,, L. Setchanova,, J. Trupl, and, P. Urbaskova. 2003. Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe. Clin. Microbiol. Infect. 9:741745.
40. Braibant, M.,, J. Chevalier,, E. Chaslus-Dancla,, J. M. Pages, and, A. Cloeckaert. 2005. Structural and functional study of the phenicol-specific efflux pump FloR belonging to the major facilitator superfamily. Antimicrob. Agents Chemother. 49:29652971.
41. Brenciani, A.,, K. K. Ojo,, A. Monachetti,, S. Menzo,, M. C. Roberts,, P. E. Varaldo, and, E. Giovanetti. 2004. Distribution and molecular analysis of mef (A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyo-genes clinical isolates with efflux-mediated erythromycin resistance. J. Antimicrob. Chemother. 54:991998.
42. Brenwald, N. P.,, M. J. Gill, and, R. Wise. 1997. The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin. J. Antimicrob. Chemother. 40:458460.
43. Brown, M. H.,, I. T. Paulsen, and, R. A. Skurray. 1999. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 31:394395.
44. Brown, M. H., and, R. A. Skurray. 2001. Staphylococcal multidrug efflux protein QacA. J. Mol. Microbiol. Biotechnol. 3:163170.
45. Brown, S. D.,, D. J. Farrell, and, I. Morrissey. 2004. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000–2001 PROTEKT US Study. J. Clin. Microbiol. 42:49804987.
46. Buchanan, S. K. 2001. Type I secretion and multidrug efflux: transport through the TolC channel-tunnel. Trends Biochem. Sci. 26:36.
47. Buckingham, S. C.,, L. K. McDougal,, L. D. Cathey,, K. Comeaux,, A. S. Craig,, S. K. Fridkin, and, F. C. Tenover. 2004. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital. Pediatr. Infect. Dis. J. 23:619624.
48. Butaye, P.,, A. Cloeckaert, and, S. Schwarz. 2003. Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria. Int. J. Anti-microb. Agents 22:205210.
49. Butler, P. J.,, I. Ubarretxena-Belandia,, T. Warne, and, C. G. Tate. 2004. The Escherichia coli multidrug transporter EmrE is a dimer in the detergent-solubilised state. J. Mol. Biol. 340:797808.
50. Calladine, C. R.,, A. Sharff, and, B. Luisi. 2001. How to untwist an alpha-helix: structural principles of an alpha-helical barrel. J. Mol. Biol. 305:603618.
51. Canton, R.,, A. Mazzariol,, M. I. Morosini,, F. Baquero, and, G. Cornaglia. 2005. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J. Antimicrob. Che-mother. 55:489495.
52. Capilla, S.,, J. Ruiz,, P. Goni,, J. Castillo,, M. C. Rubio,, M. T. Jimenez de Anta,, R. Gomez-Lus, and, J. Vila. 2004. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates. J. Antimicrob. Chemother. 53:10681071.
53. Cavallo, J. D.,, P. Plesiat,, G. Couetdic,, F. Leblanc, and, R. Fabre. 2002. Mechanisms of beta-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproduc-ing strains in a French multicentre study (1997). J. Antimi-crob. Chemother. 50:10391043.
54. Chami, M.,, E. Steinfels,, C. Orelle,, J. M. Jault,, A. Di Pietro,, J. L. Rigaud, and, S. Marco. 2002. Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis. J. Mol. Biol. 315:10751085.
55. Chan, Y. Y., and, K. L. Chua. 2005. The Burkholderia pseu-domallei BpeAB-OprB efflux pump: expression and impact on quorum sensing and virulence. J. Bacteriol. 187:47074719.
56. Chang, G. 2003. Multidrug resistance ABC transporters. FEBS Lett. 555:102105.
57. Chang, G. 2003. Structure of MsbA from Vibrio cholerae: a multidrug resistance ABC transporter homolog in a closed conformation. J. Mol. Biol. 330:419430.
58. Chang, G., and, C. B. Roth. 2001. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science 293:17931800.
59. Chen, J.,, Y. Morita,, M. N. Huda,, T. Kuroda,, T. Mizushima, and, T. Tsuchiya. 2002. VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio para-haemolyticus. J. Bacteriol. 184:572576.
60. Chesneau, O.,, H. Ligeret,, N. Hosan-Aghaie,, A. Morvan, and, E. Dassa. 2005. Molecular analysis of resistance to streptogramin A compounds conferred by the vga proteins of staphylococci. Antimicrob. Agents Chemother. 49:973980.
61. Chevalier, J.,, S. Atifi,, A. Eyraud,, A. Mahamoud,, J. Barbe, and, J. M. Pages. 2001. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. J. Med. Chem. 44:40234026.
62. Chollet, R.,, J. Chevalier,, A. Bryskier, and, J. M. Pages. 2004. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother. 48:36213624.
63. Chopra, I. 2002. New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors. Drug Resist. Updat. 5:119125.
64. Chopra, I., and, M. Roberts. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232260.
65. Chuanchuen, R.,, K. Beinlich,, T. T. Hoang,, A. Becher,, R. R. Karkhoff-Schweizer, and, H. P. Schweizer. 2001. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob. Agents Chemother. 45:428432.
66. Chung, Y. J., and, M. H. Saier, Jr. 2001. SMR-type multi-drug resistance pumps. Curr. Opin. Drug Discov. Devel. 4:237245.
67. Clancy, J.,, F. Dib-Hajj,, J. W. Petitpas, and, W. Yuan. 1997. Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Antimicrob. Agents Chemother. 41:27192723.
68. Clarebout, G.,, C. Villers, and, R. Leclercq. 2001. Macrolide resistance gene mreA of Streptococcus agalactiae encodes a flavokinase. Antimicrob. Agents Chemother. 45:22802286.
69. Coban, A. Y.,, B. Ekinci, and, B. Durupinar. 2004. A multi-drug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates. Chemotherapy 50:2226.
70. Cohen, S. P.,, L. M. McMurry,, D. C. Hooper,, J. S. Wolfson, and, S. B. Levy. 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 33:13181325.
71. Cole, E. C.,, R. M. Addison,, J. R. Rubino,, K. E. Leese,, P. D. Dulaney,, M. S. Newell,, J. Wilkins,, D. J. Gaber,, T. Wineinger, and, D. A. Criger. 2003. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J. Appl. Microbiol. 95:664676.
72. Cosson, P.,, L. Zulianello,, O. Join-Lambert,, F. Faurisson,, L. Gebbie,, M. Benghezal,, C. Van Delden,, L. K. Curty, and, T. Kohler. 2002. Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J. Bacte-riol. 184:30273033.
73. Dawson, R. J., and, K. P. Locher. 2006. Structure of a bacterial multidrug ABC transporter. Nature 443:180185.
74. Dean, C. R.,, M. A. Visalli,, S. J. Projan,, P. E. Sum, and, P. A. Bradford. 2003. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother. 47:972978.
75. De Kievit, T. R.,, M. D. Parkins,, R. J. Gillis,, R. Srikumar,, H. Ceri,, K. Poole,, B. H. Iglewski, and, D. G. Storey. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45:17611770.
76. Doerrler, W. T., and, C. R. Raetz. 2002. ATPase activity of the MsbA lipid flippase of Escherichia coli. J. Biol. Chem. 277:3669736705.
77. Dong, J.,, G. Yang, and, H. S. McHaourab. 2005. Structural basis of energy transduction in the transport cycle of MsbA. Science 308:10231028.
78. Dridi, L.,, J. Tankovic, and, J. C. Petit. 2004. CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family. Microb. Drug Resist. 10:191196.
79. Dubochet, J.,, A. W. McDowall,, B. Menge,, E. N. Schmid, and, K. G. Lickfeld. 1983. Electron microscopy of frozen-hydrated bacteria. J. Bacteriol. 155:381390.
80. Dubois, V.,, C. Arpin,, M. Melon,, B. Melon,, C. Andre,, C. Frigo, and, C. Quentin. 2001. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance. J. Clin. Microbiol. 39:20722078.
81. Dugan, J.,, D. D. Rockey,, L. Jones, and, A. A. Andersen. 2004. Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene. Antimicrob. Agents Chemother. 48:39893995.
82. Elkins, C. A., and, L. B. Mullis. 2006. Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli. J. Bacteriol. 188:11911195.
83. Elkins, C. A., and, H. Nikaido. 2002. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J. Bacteriol. 184:64906498.
84. Escribano, I.,, J. C. Rodriguez,, L. Cebrian, and, G. Royo. 2004. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int. J. Antimicrob. Agents 24:428432.
85. Eswaran, J.,, C. Hughes, and, V. Koronakis. 2003. Locking TolC entrance helices to prevent protein translocation by the bacterial type I export apparatus. J. Mol. Biol. 327:309315.
86. Farrell, D. J., and, D. Felmingham. 2004. Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003. Antimicrob. Agents Chemother. 48:18821884.
87. Farrell, D. J.,, I. Morrissey,, S. Bakker,, L. Morris,, S. Buckridge, and, D. Felmingham. 2004. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm (B)- and mef (A)-mediated macrolide resistance. J. Clin. Microbiol. 42:764768.
88. Federici, L.,, D. Du,, F. Walas,, H. Matsumura,, J. Fernandez-Recio,, K. S. McKeegan,, M. I. Borges-Walmsley,, B. F. Luisi, and, A. R. Walmsley. 2005. The crystal structure of the outer membrane protein VceC from the bacterial pathogen Vibrio cholerae at 1.8 A resolution. J. Biol. Chem. 280:1530715314.
89. Fernandes, P.,, B. S. Ferreira, and, J. M. Cabral. 2003. Solvent tolerance in bacteria: role of efflux pumps and cross-resistance with antibiotics. Int. J. Antimicrob. Agents 22:211216.
90. Ferrandiz, M. J.,, J. Oteo,, B. Aracil,, J. L. Gomez-Garces, and, A. G. De La Campa. 1999. Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. Antimicrob. Agents Chemother. 43:25202523.
91. Fleishman, S. J.,, S. E. Harrington,, A. Enosh,, D. Halperin,, C. G. Tate, and, N. Ben Tal. 2006. Quasi-symmetry in the Cryo-EM structure of EmrE provides the key to modeling its transmembrane domain. J. Mol. Biol. 364:5467.
92. Fraise, A. P. 2002. Biocide abuse and antimicrobial resistance — a cause for concern? J. Antimicrob. Chemother. 49:1112.
93. Fraise, A. P. 2002. Susceptibility of antibiotic-resistant cocci to biocides. Symp. Ser. Soc. Appl. Microbiol. 2002:158S-162S.
94. Fraise, A. P. 2002. Susceptibility of antibiotic-resistant cocci to biocides. J. Appl. Microbiol. 92(Suppl.):158S-162S.
95. Gay, K.,, W. Baughman,, Y. Miller,, D. Jackson,, C. G. Whitney,, A. Schuchat,, M. M. Farley,, F. Tenover, and, D. S. Stephens. 2000. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J. Infect. Dis. 182:14171424.
96. Gerken, H., and, R. Misra. 2004. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli. Mol. Microbiol. 54:620631.
97. Gibbons, S.,, M. Oluwatuyi, and, G. W. Kaatz. 2003. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J. Antimicrob. Chemother. 51:1317.
98. Gilbert, P.,, A. J. McBain, and, S. F. Bloomfield. 2002. Biocide abuse and antimicrobial resistance: being clear about the issues. J. Antimicrob. Chemother. 50:137139.
99. Giovanetti, E.,, A. Brenciani,, R. Burioni, and, P. E. Varaldo. 2002. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. Antimicrob. Agents Chemother. 46:37503755.
100. Giraud, E.,, G. Blanc,, A. Bouju-Albert,, F. X. Weill, and, C. Donnay-Moreno. 2004. Mechanisms of quinolone resistance and clonal relationship among Aeromonas sal-monicida strains isolated from reared fish with furunculosis. J. Med. Microbiol. 53:895901.
101. Graham, L. L.,, R. Harris,, W. Villiger, and, T. J. Beveridge. 1991. Freeze-substitution of gram-negative eubacteria: general cell morphology and envelope profiles. J. Bacteriol. 173:16231633.
102. Grkovic, S.,, M. H. Brown, and, R. A. Skurray. 2002. Regulation of bacterial drug export systems. Microbiol. Mol. Biol. Rev. 66:671701.
103. Grkovic, S.,, K. M. Hardie,, M. H. Brown, and, R. A. Skur-ray. 2003. Interactions of the QacR multidrug-binding protein with structurally diverse ligands: implications for the evolution of the binding pocket. Biochemistry 42:1522615236.
104. Grohs, P.,, S. Houssaye,, A. Aubert,, L. Gutmann, and, E. Varon. 2003. In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones. Antimicrob. Agents Chemother. 47:35423547.
105. Guan, L., and, T. Nakae. 2001. Identification of essential charged residues in transmembrane segments of the multi-drug transporter MexB of Pseudomonas aeruginosa. J. Bacteriol. 183:17341739.
106. Guerin, F.,, E. Varon,, A. B. Hoi,, L. Gutmann, and, I. Podglajen. 2000. Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci. Antimicrob. Agents Chemother. 44:21972200.
107. Gupta, A.,, K. Matsui,, J. F. Lo, and, S. Silver. 1999. Molecular basis for resistance to silver cations in Salmonella. Nat. Med. 5:183188.
108. Gutman, N.,, S. Steiner-Mordoch, and, S. Schuldiner. 2003. An amino acid cluster around the essential Glu-14 is part of the substrate- and proton-binding domain of EmrE, a multidrug transporter from Escherichia coli. J. Biol. Chem. 278:1608216087.
109. Hagman, K. E.,, C. E. Lucas,, J. T. Balthazar,, L. Snyder,, M. Nilles,, R. C. Judd, and, W. M. Shafer. 1997. The MtrD protein of Neisseria gonorrhoeae is a member of the resistance/nodulation/division protein family constituting part of an efflux system. Microbiology 143(Pt. 7):21172125.
110. Hartman, A. B.,, I. I. Essiet,, D. W. Isenbarger, and, L. E. Lindler. 2003. Epidemiology of tetracycline resistance determinants in Shigella spp. and enteroinvasive Escherichia coli: characterization and dissemination of tet (A)-1. J. Clin. Microbiol. 41:10231032.
111. He, G. X.,, T. Kuroda,, T. Mima,, Y. Morita,, T. Mizushima, and, T. Tsuchiya. 2004. An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J. Bacteriol. 186:262265.
112. Hearn, E. M.,, M. R. Gray, and, J. M. Foght. 2006. Mutations in the central cavity and periplasmic domain affect efflux activity of the resistance-nodulation-division pump EmhB from Pseudomonas fluorescens cLP6a. J. Bacteriol. 188:115123.
113. Heymann, J. A.,, T. Hirai,, D. Shi, and, S. Subramaniam. 2003. Projection structure of the bacterial oxalate transporter OxlT at 3.4A resolution. J. Struct. Biol. 144:320326.
114. Heymann, J. A.,, R. Sarker,, T. Hirai,, D. Shi,, J. L. Milne,, P. C. Maloney, and, S. Subramaniam. 2001. Projection structure and molecular architecture of OxlT, a bacterial membrane transporter. EMBO J. 20:44084413.
115. Higgins, M. K.,, E. Bokma,, E. Koronakis,, C. Hughes, and, V. Koronakis. 2004. Structure of the periplasmic component of a bacterial drug efflux pump. Proc. Natl. Acad. Sci. USA 101:99949999.
116. Higgins, M. K.,, J. Eswaran,, P. Edwards,, G. F. Schertler,, C. Hughes, and, V. Koronakis. 2004. Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC. J. Mol. Biol. 342:697702.
117. Higgins, P. G.,, H. Wisplinghoff,, D. Stefanik, and, H. Seifert. 2004. Selection of topoisomerase mutations and overexpres-sion of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J. Antimicrob. Chemother. 54:821823.
118. Hirai, T.,, J. A. Heymann,, D. Shi,, R. Sarker,, P. C. Maloney, and, S. Subramaniam. 2002. Three-dimensional structure of a bacterial oxalate transporter. Nat. Struct. Biol. 9:597600.
119. Hirai, T., and, S. Subramaniam. 2004. Structure and transport mechanism of the bacterial oxalate transporter OxlT. Biophys. J. 87:36003607.
120. Hirakata, Y.,, R. Srikumar,, K. Poole,, N. Gotoh,, T. Sue-matsu,, S. Kohno,, S. Kamihira,, R. E. Hancock, and, D. P. Speert. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109118.
121. Hirata, T.,, A. Saito,, K. Nishino,, N. Tamura, and, A. Yama-guchi. 2004. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimi-crob. Agents Chemother. 48:21792184.
122. Hirata, T.,, R. Wakatabe,, J. Nielsen,, Y. Someya,, E. Fujihira,, T. Kimura, and, A. Yamaguchi. 1997. A novel compound, 1,1-dimethyl-5(1-hydroxypropyl)-4,6,7-trimethylindan, is an effective inhibitor of the tet (K) gene-encoded metal-tetracycline/H+ antiporter of Staphylococcus aureus. FEBS Lett. 412:337340.
123. Hoban, D. J.,, A. K. Wierzbowski,, K. Nichol, and, G. G. Zhanel. 2001. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998–1999: prevalence of mef (A) and erm (B) and susceptibilities to ketolides. Antimicrob. Agents Chemother. 45:21472150.
124. Hocquet, D.,, X. Bertrand,, T. Kohler,, D. Talon, and, P. Plesiat. 2003. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob. Agents Chemother. 47:18871894.
125. Hocquet, D.,, C. Vogne,, F. El Garch,, A. Vejux,, N. Gotoh,, A. Lee,, O. Lomovskaya, and, P. Plesiat. 2003. MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 47:13711375.
126. Huang, Y.,, M. J. Lemieux,, J. Song,, M. Auer, and, D. N. Wang. 2003. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301:616620.
127. Huda, M. N.,, J. Chen,, Y. Morita,, T. Kuroda,, T. Mizushima, and, T. Tsuchiya. 2003. Gene cloning and characterization of VcrM, a Na+-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol. Immunol. 47:419427.
128. Inoue, M.,, S. Kohno,, M. Kaku,, K. Yamaguchi,, J. Igari, and, K. Yamanaka. 2005. PROTEKT 1999–2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. Int. J. Infect. Dis. 9:2736.
129. Ip, H.,, K. Stratton,, H. Zgurskaya, and, J. Liu. 2003. pH-induced conformational changes of AcrA, the membrane fusion protein of Escherichia coli multidrug efflux system. J. Biol. Chem. 278:5047450482.
130. Islam, S.,, S. Jalal, and, B. Wretlind. 2004. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 10:877883.
131. Jalal, S.,, O. Ciofu,, N. Hoiby,, N. Gotoh, and, B. Wretlind. 2000. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 44:710712.
132. Johnson, A. P.,, C. L. Sheppard,, S. J. Harnett,, A. Birtles,, T. G. Harrison,, N. P. Brenwald,, M. J. Gill,, R. A. Walker,, D. M. Livermore, and, R. C. George. 2003. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. J. Antimicrob. Chemother. 52:953960.
133. Johnson, J. M., and, G. M. Church. 1999. Alignment and structure prediction of divergent protein families: periplas-mic and outer membrane proteins of bacterial efflux pumps. J. Mol. Biol. 287:695715.
134. Johnston, N. J.,, J. C. De Azavedo,, J. D. Kellner, and, D. E. Low. 1998. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:24252426.
135. Kaatz, G. W. 2002. Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance. Expert Opin. Emerg. Drugs 7:223233.
136. Kaatz, G. W. 2005. Bacterial efflux pump inhibition. Curr. Opin. Investig. Drugs 6:191198.
137. Kaatz, G. W.,, F. McAleese, and, S. M. Seo. 2005. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob. Agents Chemother. 49:18571864.
138. Kaatz, G. W.,, V. V. Moudgal, and, S. M. Seo. 2002. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J. Antimicrob. Chemother. 50:833838.
139. Kaatz, G. W.,, V. V. Moudgal,, S. M. Seo,, J. B. Hansen, and, J. E. Kristiansen. 2003. Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Int. J. Antimicrob. Agents 22:254261.
140. Kern, W. V.,, M. Oethinger,, A. S. Jellen-Ritter, and, S. B. Levy. 2000. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimi-crob. Agents Chemother. 44:814820.
141. Kobayashi, N.,, K. Nishino,, T. Hirata, and, A. Yamaguchi. 2003. Membrane topology of ABC-type macrolide antibiotic exporter MacB in Escherichia coli. FEBS Lett. 546:241246.
142. Kobayashi, N.,, K. Nishino, and, A. Yamaguchi. 2001. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J. Bacteriol. 183:56395644.
143. Köhler, T.,, S. F. Epp,, L. K. Curty, and, J. C. Pechere. 1999. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeru-ginosa. J. Bacteriol. 181:63006305.
144. Köhler, T.,, C. Van Delden,, L. K. Curty,, M. M. Hamzehpour, and, J. C. Pechere. 2001. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol. 183:52135222.
145. Koronakis, V.,, A. Sharff,, E. Koronakis,, B. Luisi, and, C. Hughes. 2000. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914919.
146. Kozlov, R. S.,, T. M. Bogdanovitch,, P. C. Appelbaum,, L. Ednie,, L. S. Stratchounski,, M. R. Jacobs, and, B. Bozdogan. 2002. Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia. Antimicrob. Agents Chemother. 46:29632968.
147. Kumar, A., and, H. P. Schweizer. 2005. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv. Drug Deliv. Rev. 57:14861513.
148. Kutschke, A., and, B. L. de Jonge. 2005. Compound efflux in Helicobacter pylori. Antimicrob. Agents Chemother. 49:30093010.
149. Lambert, O.,, H. Benabdelhak,, M. Chami,, L. Jouan,, E. Nouaille,, A. Ducruix, and, A. Brisson. 2005. Trimeric structure of OprN and OprM efflux proteins from Pseudomonas aeruginosa, by 2D electron crystallography. J. Struct. Biol. 150:5057.
150. Le Themas, I.,, G. Couetdic,, O. Clermont,, N. Brahimi,, P. Plesiat, and, E. Bingen. 2001. In vivo selection of a target/ efflux double mutant of Pseudomonas aeruginosa by cipro-floxacin therapy. J. Antimicrob. Chemother. 48:553555.
151. Levy, S. B. 1992. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36:695703.
152. Levy, S. B. 2001. Antibacterial household products: cause for concern. Emerg. Infect. Dis. 7:512515.
153. Levy, S. B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. 92(Suppl.):65S71S.
154. Lewis, K. 2001. In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol. 3:247254.
155. Lewis, K., and, O. Lomovskaya. 2002. Drug efflux, p. 6190. In K. Lewis,, A. A. Salyers,, H. W. Taber, and, R. G. Wax (ed.), Bacterial Resistance to Antimicrobials. Marcel Dekker, Inc., New York, N.Y.
156. Li, X. Z., and, H. Nikaido. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64:159204.
157. Li, X. Z.,, H. Nikaido, and, K. Poole. 1995. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:19481953.
158. Li, X. Z.,, H. Nikaido, and, K. E. Williams. 1997. Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J. Bacteriol. 179:61276132.
159. Li, X. Z., and, K. Poole. 2001. Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 183:1227.
160. Liu, R., and, F. J. Sharom. 1996. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 35:1186511873.
161. Livermore, D. M. 2003. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36:S11S23.
162. Livermore, D. M. 2003. The threat from the pink corner. Ann. Med. 35:226234.
163. Livermore, D. M. 2004. The need for new antibiotics. Clin. Microbiol. Infect. 10(Suppl. 4):19.
164. Livermore, D. M. 2005. Tigecycline: what is it, and where should it be used? J. Antimicrob. Chemother. 56:611614.
165. Llanes, C.,, D. Hocquet,, C. Vogne,, D. Benali-Baitich,, C. Neuwirth, and, P. Plesiat. 2004. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob. Agents Chemother. 48:17971802.
166. Locher, K. P.,, A. T. Lee, and, D. C. Rees. 2002. The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296:10911098.
167. Lomovskaya, O., and, K. A. Bostian. 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic— a vision for applied use. Biochem. Pharmacol. 71:910918.
168. Lomovskaya, O.,, M. S. Warren,, A. Lee,, J. Galazzo,, R. Fronko,, M. Lee,, J. Blais,, D. Cho,, S. Chamberland,, T. Renau,, R. Leger,, S. Hecker,, W. Watkins,, K. Hoshino,, H. Ishida, and, V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105116.
169. Lomovskaya, O., and, W. Watkins. 2001. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J. Mol. Microbiol. Biotechnol. 3:225236.
170. Lonks, J. R.,, J. Garau, and, A. A. Medeiros. 2002. Implications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: the case of macrolides. J. Antimicrob. Chemother. 50(Suppl. S2): 8792.
171. Lynch, A. S. 2005. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. Biochem. Pharmacol. 71:949956.
172. Lynch, J. P., III, and, F. J. Martinez. 2002. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin. Infect. Dis. 34(Suppl 1): S27S46.
173. Ma, C., and, G. Chang. 2004. Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli. Proc. Natl. Acad. Sci. USA 101:28522857.
174. Mao, W.,, M. S. Warren,, D. S. Black,, T. Satou,, T. Murata,, T. Nishino,, N. Gotoh, and, O. Lomovskaya. 2002. On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Mol. Microbiol. 46:889901.
175. Marchandin, H.,, H. Jean-Pierre,, E. Jumas-Bilak,, L. Isson,, B. Drouillard,, H. Darbas, and, C. Carriere. 2001. Distribution of macrolide resistance genes erm (B) and mef (A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France. Pathol. Biol. (Paris) 49:522527.
176. Markham, P. N. 1999. Inhibition of the emergence of cipro-floxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrob. Agents Chemother. 43:988989.
177. Markham, P. N., and, A. A. Neyfakh. 1996. Inhibition of the multidrug transporter NorA prevents emergence of norflox-acin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:26732674.
178. Markham, P. N., and, A. A. Neyfakh. 2001. Efflux-mediated drug resistance in Gram-positive bacteria. Curr. Opin. Microbiol. 4:509514.
179. Markham, P. N.,, E. Westhaus,, K. Klyachko,, M. E. Johnson, and, A. A. Neyfakh. 1999. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:24042408.
180. Marquez, B. 2005. Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87:11371147.
181. Maseda, H.,, I. Sawada,, K. Saito,, H. Uchiyama,, T. Nakae, and, N. Nomura. 2004. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:13201328.
182. Mason, E. O., Jr.,, E. R. Wald,, J. S. Bradley,, W. J. Barson, and, S. L. Kaplan. 2003. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr. Infect. Dis. J. 22:623627.
183. McAleese, F.,, P. Petersen,, A. Ruzin,, P. M. Dunman,, E. Murphy,, S. J. Projan, and, P. A. Bradford. 2005. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob. Agents Chemother. 49:18651871.
184. McGee, L.,, K. P. Klugman,, A. Wasas,, T. Capper, and, A. Brink. 2001. Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm (B) and mef (A)) in South Africa. Antimicrob. Agents Chemother. 45:15951598.
185. McMurry, L.,, R. E. Petrucci, Jr., and, S. B. Levy. 1980. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. USA 77:39743977.
186. Mechetner, E. B.,, B. Schott,, B. S. Morse,, W. D. Stein,, T. Druley,, K. A. Davis,, T. Tsuruo, and, I. B. Roninson. 1997. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity. Proc. Natl. Acad. Sci. USA 94:1290812913.
187. Mendes, C.,, M. E. Marin,, F. Quinones,, J. Sifuentes-Osornio,, C. C. Siller,, M. Castanheira,, C. M. Zoccoli,, H. Lopez,, A. Sucari,, F. Rossi,, G. B. Angulo,, A. J. Segura,, C. Starling,, I. Mimica, and, D. Felmingham. 2003. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999–2000). Braz. J. Infect. Dis. 7:4461.
188. Mendez, C., and, J. A. Salas. 1998. ABC transporters in antibiotic-producing actinomycetes. FEMS Microbiol. Lett. 158:18.
189. Middlemiss, J. K., and, K. Poole. 2004. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa. J. Bacteriol. 186:12581269.
190. Mikolosko, J.,, K. Bobyk,, H. I. Zgurskaya, and, P. Ghosh. 2006. Conformational flexibility in the multidrug efflux system protein AcrA. Structure 14:577587.
191. Mitchell, B. A.,, I. T. Paulsen,, M. H. Brown, and, R. A. Skur-ray. 1999. Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J. Biol. Chem. 274:35413548.
192. Miyamae, S.,, O. Ueda,, F. Yoshimura,, J. Hwang,, Y. Tanaka, and, H. Nikaido. 2001. A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob. Agents Chemother. 45:33413346.
193. Mokhonov, V. V.,, E. I. Mokhonova,, H. Akama, and, T. Nakae. 2004. Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 322:483489.
194. Morita, Y.,, K. Kodama,, S. Shiota,, T. Mine,, A. Kataoka,, T. Mizushima, and, T. Tsuchiya. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Che-mother. 42:17781782.
195. Mortimer, P. G., and, L. J. Piddock. 1991. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 28:639653.
196. Mullin, S.,, N. Mani, and, T. H. Grossman. 2004. Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853). Antimicrob. Agents Chemother. 48:41714176.
197. Murakami, S.,, R. Nakashima,, E. Yamashita,, T. Matsu-moto, and, A. Yamaguchi. 2006. Crystal structures of a mul-tidrug transporter reveal a functionally rotating mechanism. Nature 443:173179.
198. Murakami, S.,, R. Nakashima,, E. Yamashita, and, A. Yama-guchi. 2002. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587593.
199. Murakami, S.,, N. Tamura,, A. Saito,, T. Hirata, and, A. Yamaguchi. 2004. Extramembrane central pore of multi-drug exporter AcrB in Escherichia coli plays an important role in drug transport. J. Biol. Chem. 279:37433748.
200. Muth, T. R., and, S. Schuldiner. 2000. A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE. EMBO J. 19:234240.
201. Narita, S.,, S. Eda,, E. Yoshihara, and, T. Nakae. 2003. Linkage of the efflux-pump expression level with substrate extrusion rate in the MexAB-OprM efflux pump of Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 308:922926.
202. Nehme, D.,, X. Z. Li,, R. Elliot, and, K. Poole. 2004. Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB. J. Bacteriol. 186:29732983.
203. Nies, D. H. 2003. Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol. Rev. 27:313339.
204. Nikaido, H.,, M. Basina,, V. Nguyen, and, E. Y. Rosenberg. 1998. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains. J. Bacteriol. 180:46864692.
205. Nikaido, H., and, H. I. Zgurskaya. 2001. AcrAB and related multidrug efflux pumps of Escherichia coli. J. Mol. Micro-biol. Biotechnol. 3:215218.
206. Ninio, S.,, D. Rotem, and, S. Schuldiner. 2001. Functional analysis of novel multidrug transporters from human pathogens. J. Biol. Chem. 276:4825048256.
207. Ojo, K. K.,, C. Ulep,, N. Van Kirk,, H. Luis,, M. Bernardo,, J. Leitao, and, M. C. Roberts. 2004. The mef (A) gene predominates among seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob. Agents Chemother. 48:34513456.
208. Pages, J. M.,, M. Masi, and, J. Barbe. 2005. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 11:382389.
209. Paulsen, I. T. 2003. Multidrug efflux pumps and resistance: regulation and evolution. Curr. Opin. Microbiol. 6:446451.
210. Paulsen, I. T.,, M. H. Brown,, T. G. Littlejohn,, B. A. Mitchell, and, R. A. Skurray. 1996. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. USA 93:36303635.
211. Paulsen, I. T.,, R. A. Skurray,, R. Tam,, M. H. Saier, Jr.,, R. J. Turner,, J. H. Weiner,, E. B. Goldberg, and, L. L. Grinius. 1996. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 19:11671175.
212. Pearson, J. P.,, C. Van Delden, and, B. H. Iglewski. 1999. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181:12031210.
213. Perez-Trallero, E.,, C. Fernandez-Mazarrasa,, C. Garcia-Rey,, E. Bouza,, L. Aguilar,, J. Garcia-de-Lomas, and, F. Baquero. 2001. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998–1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45:33343340.
214. Piddock, L. J. 1999. Mechanisms of fluoroquinolone resistance: an update 1994–1998. Drugs 58(Suppl. 2):1118.
215. Piddock, L. J. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19:382402.
216. Piddock, L. J. 2006. Multidrug-resistance efflux pumps — not just for resistance. Nat. Rev. Microbiol. 4:629636.
217. Pihlajamaki, M.,, J. Jalava,, P. Huovinen, and, P. Kotilainen. 2003. Antimicrobial resistance of invasive pneumococci in Finland in 1999–2000. Antimicrob. Agents Chemother. 47:18321835.
218. Poole, K. 2000. Efflux-mediated resistance to fluoro-quinolones in gram-negative bacteria. Antimicrob. Agents Chemother. 44:22332241.
219. Poole, K. 2000. Efflux-mediated resistance to fluoroquino-lones in gram-positive bacteria and the mycobacteria. Antimicrob. Agents Chemother. 44:25952599.
220. Poole, K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3:255264.
221. Poole, K. 2002. Mechanisms of bacterial biocide and antibiotic resistance. J. Appl. Microbiol. 92(Suppl.):55S64S.
222. Poole, K. 2004. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10:1226.
223. Poole, K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:2051.
224. Poole, K., and, O. Lomovskaya. 2006. Can efflux inhibitors really counter resistance? Drug Discov. Today 3:145152.
225. Pornillos, O.,, Y. J. Chen,, A. P. Chen, and, G. Chang. 2005. X-ray structure of the EmrE multidrug transporter in complex with a substrate. Science 310:19501953.
226. Pos, K. M., and, K. Diederichs. 2002. Purification, crystallization and preliminary diffraction studies of AcrB, an inner-membrane multi-drug efflux protein. Acta Crystallogr. D. Biol. Crystallogr. 58:18651867.
227. Pos, K. M.,, A. Schiefner,, M. A. Seeger, and, K. Diederichs. 2004. Crystallographic analysis of AcrB. FEBS Lett. 564:333339.
228. Putman, M.,, H. W. van Veen, and, W. N. Konings. 2000. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64:672693.
229. Quale, J.,, S. Bratu,, D. Landman, and, R. Heddurshetti. 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis. 37:214220.
230. Quentin, Y., and, G. Fichant. 2000. ABCdb: an ABC transporter database. J. Mol. Microbiol. Biotechnol. 2:501504.
231. Ramos, J. L.,, E. Duque,, M. T. Gallegos,, P. Godoy,, M. I. Ramos-Gonzalez,, A. Rojas,, W. Teran, and, A. Segura. 2002. Mechanisms of solvent tolerance in gram-negative bacteria. Annu. Rev. Microbiol. 56:743768.
232. Randall, L. P., and, M. J. Woodward. 2002. The multiple antibiotic resistance (mar) locus and its significance. Res. Vet. Sci. 72:8793.
233. Reinert, R. R.,, C. Franken,, M. van der Linden,, R. Lutticken,, M. Cil, and, A. Al Lahham. 2004. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002–2003. Int. J. Antimicrob. Agents 24:4347.
234. Reinert, R. R.,, R. Lutticken,, S. Reinert,, A. Al Lahham, and, S. Lemmen. 2004. Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999–2000. Chemotherapy 50:184189.
235. Reinert, R. R.,, R. Lutticken,, J. A. Sutcliffe,, A. Tait-Kamradt,, M. Y. Cil,, H. M. Schorn,, A. Bryskier, and, A. Al Lahham. 2004. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob. Agents Chemother. 48:13691373.
236. Renau, T. E. 2001. Efflux pump inhibitors to address bacterial and fungal resistance. Drugs Future 26:11711178.
237. Renau, T. E.,, R. Leger,, L. Filonova,, E. M. Flamme,, M. Wang,, R. Yen,, D. Madsen,, D. Griffith,, S. Chamberland,, M. N. Dudley,, V. J. Lee,, O. Lomovskaya,, W. J. Watkins,, T. Ohta,, K. Nakayama, and, Y. Ishida. 2003. Confor-mationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg. Med. Chem. Lett. 13:27552758.
238. Renau, T. E.,, R. Leger,, E. M. Flamme,, J. Sangalang,, M. W. She,, R. Yen,, C. L. Gannon,, D. Griffith,, S. Chamberland,, O. Lomovskaya,, S. J. Hecker,, V. J. Lee,, T. Ohta, and, K. Nakayama. 1999. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42:49284931.
239. Renau, T. E.,, R. Leger,, R. Yen,, M. W. She,, E. M. Flamme,, J. Sangalang,, C. L. Gannon,, S. Chamberland,, O. Lomov-skaya, and, V. J. Lee. 2002. Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg. Med. Chem. Lett. 12:763766.
240. Reuter, G.,, T. Janvilisri,, H. Venter,, S. Shahi,, L. Bala-krishnan, and, H. W. van Veen. 2003. The ATP binding cassette multidrug transporter LmrA and lipid transporter MsbA have overlapping substrate specificities. J. Biol. Chem. 278:3519335198.
241. Reyes, C. L., and, G. Chang. 2005. Structure of the ABC transporter MsbA in complex with ADP.vanadate and lipopolysaccharide. Science 308:10281031.
242. Reyes, C. L.,, A. Ward,, J. Yu, and, G. Chang. 2006. The structures of MsbA: insight into ABC transporter-mediated multidrug efflux. FEBS Lett. 580:10421048.
243. Reynolds, E.,, J. I. Ross, and, J. H. Cove. 2003. Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters? Int. J. Antimicrob. Agents 22:228236.
244. Ribera, A.,, J. Ruiz,, M. T. Jiminez de Anta, and, J. Vila. 2002. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Steno-trophomonas maltophilia clinical isolates. J. Antimicrob. Chemother. 49:697698.
245. Rice, L. B. 2006. Challenges in identifying new antimicrobial agents effective for treating infections with Acineto-bacter baumannii and Pseudomonas aeruginosa. Clin. Infect. Dis. 43(Suppl. 2):S100S105.
246. Roberts, M. C. 2003. Tetracycline therapy: update. Clin. Infect. Dis. 36:462467.
247. Roberts, M. C. 2005. Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett. 245:195203.
248. Roberts, M. C.,, J. Sutcliffe,, P. Courvalin,, L. B. Jensen,, J. Rood, and, H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:28232830.